Efficacy of DMARDs and methylprednisolone treatment on the gene expression levels of HSPA5, MMD, and non-coding RNAs MALAT1, H19, miR-199a-5p, and miR-1-3p, in patients with rheumatoid arthritis
•MALAT1 and H19 may be candidates as potential biomarkers in rheumatoid arthritis.•MALAT1 and H19 positively correlated with MMD and RA severity.•DMARDs plus mPRED were not effective in reducing HSPA5 and MMD gene expression. Rheumatoid arthritis (RA) is a systemic autoimmune disease with chronic in...
Saved in:
Published in | International immunopharmacology Vol. 108; p. 108878 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.07.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •MALAT1 and H19 may be candidates as potential biomarkers in rheumatoid arthritis.•MALAT1 and H19 positively correlated with MMD and RA severity.•DMARDs plus mPRED were not effective in reducing HSPA5 and MMD gene expression.
Rheumatoid arthritis (RA) is a systemic autoimmune disease with chronic inflammation characterized by joint damage and even extra-articular involvement. In this study, the gene expression levels of MALAT1, H19 and their possible downstream microRNAs, miR-199a-5p, miR-1-3p, and the predicted targets of these miRNAs, HSPA5 and MMD, were examined.
Twenty-five newly diagnosed RA patients and 25 healthy individuals were included. For six months, patients were treated with conventional disease-modifying antirheumatic drugs (DMARDs) and Methylprednisolone (mPRED). Blood samples were obtained from healthy controls and patients (before and after treatment). After RNA extraction, the RT-qPCR technique was used to evaluate the expression level of the studied genes.
Data showed that the expression level of MALAT1, H19, miR-199a-5p, and miR-1-3p was significantly higher in the newly diagnosed patients with RA than the healthy subjects, but the increase in the expression level of HSPA5 and MMD genes in the new cases was not significant compared to healthy controls. After treatment, except for the expression level of lncRNAs, the expression level of miRNAs, HSPA5, and MMD significantly increased. Based on ROC curve analysis of MALAT1, H19, miR-199a-5p and miR-1-3p have a high ability to identify patients from healthy individuals (AUC = 0.986, AUC = 0.995, AUC = 0.855, AUC = 0.675, respectively).
MALAT1 and H19 may be candidates as potential biomarkers for the discrimination between RA patients and controls. DMARDs plus mPRED therapy do not have a desirable effect on reducing inflammatory responses and ER stress. |
---|---|
AbstractList | •MALAT1 and H19 may be candidates as potential biomarkers in rheumatoid arthritis.•MALAT1 and H19 positively correlated with MMD and RA severity.•DMARDs plus mPRED were not effective in reducing HSPA5 and MMD gene expression.
Rheumatoid arthritis (RA) is a systemic autoimmune disease with chronic inflammation characterized by joint damage and even extra-articular involvement. In this study, the gene expression levels of MALAT1, H19 and their possible downstream microRNAs, miR-199a-5p, miR-1-3p, and the predicted targets of these miRNAs, HSPA5 and MMD, were examined.
Twenty-five newly diagnosed RA patients and 25 healthy individuals were included. For six months, patients were treated with conventional disease-modifying antirheumatic drugs (DMARDs) and Methylprednisolone (mPRED). Blood samples were obtained from healthy controls and patients (before and after treatment). After RNA extraction, the RT-qPCR technique was used to evaluate the expression level of the studied genes.
Data showed that the expression level of MALAT1, H19, miR-199a-5p, and miR-1-3p was significantly higher in the newly diagnosed patients with RA than the healthy subjects, but the increase in the expression level of HSPA5 and MMD genes in the new cases was not significant compared to healthy controls. After treatment, except for the expression level of lncRNAs, the expression level of miRNAs, HSPA5, and MMD significantly increased. Based on ROC curve analysis of MALAT1, H19, miR-199a-5p and miR-1-3p have a high ability to identify patients from healthy individuals (AUC = 0.986, AUC = 0.995, AUC = 0.855, AUC = 0.675, respectively).
MALAT1 and H19 may be candidates as potential biomarkers for the discrimination between RA patients and controls. DMARDs plus mPRED therapy do not have a desirable effect on reducing inflammatory responses and ER stress. Rheumatoid arthritis (RA) is a systemic autoimmune disease with chronic inflammation characterized by joint damage and even extra-articular involvement. In this study, the gene expression levels of MALAT1, H19 and their possible downstream microRNAs, miR-199a-5p, miR-1-3p, and the predicted targets of these miRNAs, HSPA5 and MMD, were examined. Twenty-five newly diagnosed RA patients and 25 healthy individuals were included. For six months, patients were treated with conventional disease-modifying antirheumatic drugs (DMARDs) and Methylprednisolone (mPRED). Blood samples were obtained from healthy controls and patients (before and after treatment). After RNA extraction, the RT-qPCR technique was used to evaluate the expression level of the studied genes. Data showed that the expression level of MALAT1, H19, miR-199a-5p, and miR-1-3p was significantly higher in the newly diagnosed patients with RA than the healthy subjects, but the increase in the expression level of HSPA5 and MMD genes in the new cases was not significant compared to healthy controls. After treatment, except for the expression level of lncRNAs, the expression level of miRNAs, HSPA5, and MMD significantly increased. Based on ROC curve analysis of MALAT1, H19, miR-199a-5p and miR-1-3p have a high ability to identify patients from healthy individuals (AUC = 0.986, AUC = 0.995, AUC = 0.855, AUC = 0.675, respectively). MALAT1 and H19 may be candidates as potential biomarkers for the discrimination between RA patients and controls. DMARDs plus mPRED therapy do not have a desirable effect on reducing inflammatory responses and ER stress. BACKGROUNDRheumatoid arthritis (RA) is a systemic autoimmune disease with chronic inflammation characterized by joint damage and even extra-articular involvement. In this study, the gene expression levels of MALAT1, H19 and their possible downstream microRNAs, miR-199a-5p, miR-1-3p, and the predicted targets of these miRNAs, HSPA5 and MMD, were examined. METHODSTwenty-five newly diagnosed RA patients and 25 healthy individuals were included. For six months, patients were treated with conventional disease-modifying antirheumatic drugs (DMARDs) and Methylprednisolone (mPRED). Blood samples were obtained from healthy controls and patients (before and after treatment). After RNA extraction, the RT-qPCR technique was used to evaluate the expression level of the studied genes. RESULTSData showed that the expression level of MALAT1, H19, miR-199a-5p, and miR-1-3p was significantly higher in the newly diagnosed patients with RA than the healthy subjects, but the increase in the expression level of HSPA5 and MMD genes in the new cases was not significant compared to healthy controls. After treatment, except for the expression level of lncRNAs, the expression level of miRNAs, HSPA5, and MMD significantly increased. Based on ROC curve analysis of MALAT1, H19, miR-199a-5p and miR-1-3p have a high ability to identify patients from healthy individuals (AUC = 0.986, AUC = 0.995, AUC = 0.855, AUC = 0.675, respectively). CONCLUSIONMALAT1 and H19 may be candidates as potential biomarkers for the discrimination between RA patients and controls. DMARDs plus mPRED therapy do not have a desirable effect on reducing inflammatory responses and ER stress. |
ArticleNumber | 108878 |
Author | Roghani, Seyed Askar Soufivand, Parviz Salari, Farhad Rezaiemanesh, Alireza Pournazari, Mehran Assar, Shirin Karamali, Negin Mahmoudi, Zahra |
Author_xml | – sequence: 1 givenname: Zahra surname: Mahmoudi fullname: Mahmoudi, Zahra organization: Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 2 givenname: Negin surname: Karamali fullname: Karamali, Negin organization: Student Research Committee, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 3 givenname: Seyed Askar surname: Roghani fullname: Roghani, Seyed Askar organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 4 givenname: Shirin surname: Assar fullname: Assar, Shirin organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 5 givenname: Mehran surname: Pournazari fullname: Pournazari, Mehran organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 6 givenname: Parviz surname: Soufivand fullname: Soufivand, Parviz organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 7 givenname: Farhad surname: Salari fullname: Salari, Farhad organization: Department of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 8 givenname: Alireza orcidid: 0000-0003-2551-705X surname: Rezaiemanesh fullname: Rezaiemanesh, Alireza email: alireza.rezaiemanesh@kums.ac.ir organization: Department of Immunology, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35623291$$D View this record in MEDLINE/PubMed |
BookMark | eNp9UU1vEzEUtFAR_YB_gJCPHLLB9sbr9QVp1ZQGKQEUytny2m8bR_uF7RTy9_rLcLqFI6dnj-bNPM1corN-6AGht5TMKaHFh_3c9dF145wRxhJUlqJ8gS5oGhkVhJ-lNy9ExkUhz9FlCHtCEr6gr9B5zguWM0kv0ONN0zijzREPDV5uqu0yYN1b3EHcHdvRg-1dGNpkjaMHHTvoIx56HHeA7yGh8DuRQnAJa-EB2nASWn3_VvEZ3myWsye1dHpmBuv6e7z9UgW8qdbVHZ3hFZUz3LltRqXUGR8n9hOQ5ennejzq6JJnwL9c3GG_g0On4-As1j7uvIsuvEYvG90GePM8r9CPTzd316ts_fX283W1zgyTLGacQ1MCS5Ewo0suaAGF5JQ0TFpZ56auRcFLAbUE3TS0toSJpi4LsKI0xNj8Cr2fdEc__DxAiKpzwUDb6h6GQ1CsEJQJIskiURcT1fghBA-NGr3rtD8qStSpPbVXU3vq1J6a2ktr754dDnUH9t_S37oS4eNESDnDgwOvgknpGLDOg4nKDu7_Dn8AtiuuGg |
CitedBy_id | crossref_primary_10_1007_s13770_023_00587_0 crossref_primary_10_1016_j_intimp_2024_112280 crossref_primary_10_1007_s10067_023_06808_0 crossref_primary_10_1111_jcmm_17770 crossref_primary_10_3390_cells12111498 crossref_primary_10_1016_j_prp_2023_155041 crossref_primary_10_1111_jcmm_18460 crossref_primary_10_1186_s12891_024_07396_z crossref_primary_10_3390_biomedicines12061322 crossref_primary_10_3389_fendo_2022_1054827 |
Cites_doi | 10.2217/pme-2020-0009 10.1016/j.imlet.2022.03.004 10.1136/annrheumdis-2011-201052 10.2147/CMAR.S169406 10.1001/jama.2018.13103 10.1016/S0140-6736(10)60826-4 10.1016/j.cell.2009.02.006 10.1002/art.27584 10.1111/imm.13303 10.1016/j.intimp.2021.107402 10.1111/cpr.12404 10.1016/j.semarthrit.2006.08.006 10.1016/j.bbagrm.2019.194417 10.1016/j.molmed.2012.06.010 10.1111/jcmm.14591 10.1002/art.23429 10.1016/j.bbrc.2014.06.075 10.1126/science.1209038 10.1038/nrg3606 10.3389/fimmu.2018.01662 10.1084/jem.20111783 10.1002/art.20999 10.1159/000480211 10.1016/j.ebiom.2019.11.024 10.1002/jcp.28811 10.1186/1471-2474-11-209 10.1016/j.tips.2018.03.010 10.1038/nrdp.2018.1 10.1093/rheumatology/35.12.1263 10.3389/fimmu.2019.03129 10.1080/14397595.2016.1259716 10.1016/j.immuni.2017.02.006 10.1002/biof.1659 10.1371/journal.pone.0053823 10.1002/mc.10075 10.1016/j.bcp.2019.03.029 10.1016/S0140-6736(01)06075-5 10.1038/nrrheum.2016.91 10.1016/j.celrep.2012.06.003 10.1093/nar/gkn714 10.3892/mmr.2015.3642 10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO;2-I 10.1101/gad.13.10.1211 10.1006/bbrc.1995.2825 10.1002/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z |
ContentType | Journal Article |
Copyright | 2022 Elsevier B.V. Copyright © 2022 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2022 Elsevier B.V. – notice: Copyright © 2022 Elsevier B.V. All rights reserved. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.intimp.2022.108878 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1878-1705 |
EndPage | 108878 |
ExternalDocumentID | 10_1016_j_intimp_2022_108878 35623291 S1567576922003629 |
Genre | Journal Article |
GroupedDBID | --- --K --M .GJ .~1 0R~ 1B1 1RT 1~. 1~5 29J 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AAAJQ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATCM AAXUO ABBQC ABFNM ABFRF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACIWK ACPRK ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFRAH AFTJW AFXIZ AGEKW AGHFR AGUBO AGYEJ AI. AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV C45 CJTIS CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM L7B LCYCR LUGTX M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SES SEW SPCBC SSH SSI SSP SSZ T5K TEORI UNMZH VH1 ZGI ~G- AAXKI AKRWK NPM AAYXX AFJKZ CITATION 7X8 |
ID | FETCH-LOGICAL-c292t-55ef8e25672ca85716e69510f29d9b3cbb76587eb9eaff1bd027fb86ed78c0cd3 |
IEDL.DBID | AIKHN |
ISSN | 1567-5769 |
IngestDate | Sat Oct 05 06:14:25 EDT 2024 Thu Sep 26 20:08:58 EDT 2024 Sat Sep 28 08:18:37 EDT 2024 Fri Feb 23 02:42:22 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | MEG3 lncRNA JNK FACS DMARDs Anti-CCP ncRNA ncRNAs ETS1 TNF TH17 cell AUC NF-κB HIF1-α IRE1 miRNA PAQR1 WBC cDNA ROC curve RT-qPCR DAS28 HSPA5 circRNA MMD ESR MACS STAT3 mPRED MAPK NEAT1 ER PBMC IL-6 RA ACR PICSAR APC Rheumatoid arthritis EULAR MALAT1 ATF6 XBP1s |
Language | English |
License | Copyright © 2022 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c292t-55ef8e25672ca85716e69510f29d9b3cbb76587eb9eaff1bd027fb86ed78c0cd3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2551-705X |
PMID | 35623291 |
PQID | 2671270904 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2671270904 crossref_primary_10_1016_j_intimp_2022_108878 pubmed_primary_35623291 elsevier_sciencedirect_doi_10_1016_j_intimp_2022_108878 |
PublicationCentury | 2000 |
PublicationDate | 2022-07-01 |
PublicationDateYYYYMMDD | 2022-07-01 |
PublicationDate_xml | – month: 07 year: 2022 text: 2022-07-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | International immunopharmacology |
PublicationTitleAlternate | Int Immunopharmacol |
PublicationYear | 2022 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Li, Zhu, Zhang, Hu, Wang, Zhu (b0125) 2018; 10 Mulherin, Fitzgerald, Bresnihan (b0055) 1996; 35 Rezaiemanesh, Mahmoudi, Amirzargar, Vojdanian, Jamshidi, Nicknam (b0160) 2017; 27 Rehli, Krause, Schwarzfischer, Kreutz, Andreesen (b0100) 1995; 217 Aletaha, Neogi, Silman, Funovits, Felson, Bingham, Birnbaum, Burmester, Bykerk, Cohen (b0005) 2010; 62 Walter, Ron (b0080) 2011; 334 Yoo, You, Yoon, Kim, Kim, Lee, Ahn, Hwang, Lee, Kim, Park, Cho, Kim (b0085) 2012; 209 Firestein, McInnes (b0065) 2017; 46 Niimoto, Nakasa, Ishikawa, Okuhara, Izumi, Deie, Suzuki, Adachi, Ochi (b0225) 2010; 11 Li, Liu, Meng, Xia, Wu, Fang, Zhang, Zhang, Liu (b0190) 2019; 23 Kaufman (b0155) 1999; 13 Wang, Yan, Yang, Lu, Xu, Wang (b0185) 2019; 10 Li, Ma, Zhao, Zhang (b0245) 2020; 24 Siouti, Andreakos (b0170) 2019; 165 Silman, Pearson (b0020) 2002; 4 Aletaha, Smolen (b0035) 2018; 320 Ponting, Oliver, Reik (b0115) 2009; 136 Smolen, Aletaha, Barton, Burmester, Emery, Firestein, Kavanaugh, McInnes, Solomon, Strand, Yamamoto (b0010) 2018; 4 Jalali, Bhartiya, Lalwani, Sivasubbu, Scaria (b0140) 2013; 8 Bi, Guo, Mo, Wang, Luo, Chen, Liu, Olsen, Pan, Zheng (b0195) 2019; 50 Rahmati, Moosavi, McDermott, Stress (b0075) 2018; 39 Fatica, Bozzoni (b0110) 2014; 15 Wang, Luo, Wang, Yang, Cui (b0240) 2017; 42 Zhang, Arun, Mao, Lazar, Hung, Bhattacharjee, Xiao, Booth, Wu, Zhang (b0120) 2012; 2 Khatun, Risk, Giddings (b0180) 2012 Garg, Kaczmarek, Krysko, Vandenabeele, Krysko, Agostinis (b0070) 2012; 18 Li, He (b0165) 2014; 450 Yang, Yang (b0230) 2015; 12 Scott, Wolfe, Huizinga (b0050) 2010; 376 Chatterjee, Bhattcharjee, Misra, Saha, Bhattacharyya, Ghosh (b0215) 2020; 17 Kong, Lan, Chen, Zheng, Su, Wang, Yang, Park, Dagliyan, Conti (b0040) 2012; 71 Kinne, Stuhlmüller, Burmester (b0095) 2007; 9 Panni, Lovering, Porras, Orchard (b0105) 2020; 1863 Zhu, Zhu, Ding, Zhang, Guan, Li, Lin, Zhang, Huang, Zhang (b0210) 2021; 93 Li, Li, Jiang, Qian, Tse, Chan, Wu (b0145) 2018; 51 Yang, Li, Wang, Zhang, Li, Jia (b0205) 2020; 46 S. Ayesh, I. Matouk, T. Schneider, P. Ohana, M. Laster, W. Al-Sharef, N. de-Groot, A. Hochberg, Possible physiological role of H19 RNA, Molecular Carcinogenesis 35(2) (2002) 63-74. Lin, Huang, Wang, You, Zhang, Chen (b0175) 2021; 163 Shui, Chen, Lin, Kong, Zhou, Wu (b0200) 2019; 234 Gabriel, Crowson, O'Fallon (b0025) 1999; 42 Ariel, de Groot, Hochberg (b0130) 2000; 91 Alarcón-Segovia, Alarcón-Riquelme, Cardiel, Caeiro, Massardo, Villa, Pons-Estel, Eritematoso (b0150) 2005; 52 Nakasa, Miyaki, Okubo, Hashimoto, Nishida, Ochi, Asahara (b0235) 2008; 58 Rajabinejad, Asadi, Ranjbar, Rezaei Varmaziar, Karimi, Salari, Gorgin Karaji, Rezaiemanesh, Afshar Hezarkhani (b9000) 2022; 245 Lee, Weinblatt (b0045) 2001; 358 Chen, Wang, Xu, Huang, Qian, Ma, Lewis, June, Schafer, Lin (b0060) 2018; 9 Q. Jiang, Y. Wang, Y. Hao, L. Juan, M. Teng, X. Zhang, M. Li, G. Wang, Y. Liu, miR2Disease: a manually curated database for microRNA deregulation in human disease, Nucleic Acids Res 37(Database issue) (2009) D98-104. Tak, Kalden (b0030) 2011; 13 Alamanos, Voulgari, Drosos (b0015) 2006 Udalova, Mantovani, Feldmann (b0090) 2016; 12 10.1016/j.intimp.2022.108878_b0220 Gabriel (10.1016/j.intimp.2022.108878_b0025) 1999; 42 Rahmati (10.1016/j.intimp.2022.108878_b0075) 2018; 39 Scott (10.1016/j.intimp.2022.108878_b0050) 2010; 376 Aletaha (10.1016/j.intimp.2022.108878_b0005) 2010; 62 Bi (10.1016/j.intimp.2022.108878_b0195) 2019; 50 Chatterjee (10.1016/j.intimp.2022.108878_b0215) 2020; 17 Mulherin (10.1016/j.intimp.2022.108878_b0055) 1996; 35 Li (10.1016/j.intimp.2022.108878_b0165) 2014; 450 Alamanos (10.1016/j.intimp.2022.108878_b0015) 2006 Siouti (10.1016/j.intimp.2022.108878_b0170) 2019; 165 Alarcón-Segovia (10.1016/j.intimp.2022.108878_b0150) 2005; 52 Li (10.1016/j.intimp.2022.108878_b0145) 2018; 51 Rezaiemanesh (10.1016/j.intimp.2022.108878_b0160) 2017; 27 Li (10.1016/j.intimp.2022.108878_b0245) 2020; 24 Silman (10.1016/j.intimp.2022.108878_b0020) 2002; 4 Ariel (10.1016/j.intimp.2022.108878_b0130) 2000; 91 Zhu (10.1016/j.intimp.2022.108878_b0210) 2021; 93 Zhang (10.1016/j.intimp.2022.108878_b0120) 2012; 2 Niimoto (10.1016/j.intimp.2022.108878_b0225) 2010; 11 Udalova (10.1016/j.intimp.2022.108878_b0090) 2016; 12 Shui (10.1016/j.intimp.2022.108878_b0200) 2019; 234 Kong (10.1016/j.intimp.2022.108878_b0040) 2012; 71 Kinne (10.1016/j.intimp.2022.108878_b0095) 2007; 9 Ponting (10.1016/j.intimp.2022.108878_b0115) 2009; 136 Rehli (10.1016/j.intimp.2022.108878_b0100) 1995; 217 Jalali (10.1016/j.intimp.2022.108878_b0140) 2013; 8 Wang (10.1016/j.intimp.2022.108878_b0185) 2019; 10 Fatica (10.1016/j.intimp.2022.108878_b0110) 2014; 15 Garg (10.1016/j.intimp.2022.108878_b0070) 2012; 18 Rajabinejad (10.1016/j.intimp.2022.108878_b9000) 2022; 245 Tak (10.1016/j.intimp.2022.108878_b0030) 2011; 13 Yang (10.1016/j.intimp.2022.108878_b0230) 2015; 12 Chen (10.1016/j.intimp.2022.108878_b0060) 2018; 9 Panni (10.1016/j.intimp.2022.108878_b0105) 2020; 1863 Khatun (10.1016/j.intimp.2022.108878_b0180) 2012 Smolen (10.1016/j.intimp.2022.108878_b0010) 2018; 4 Kaufman (10.1016/j.intimp.2022.108878_b0155) 1999; 13 Firestein (10.1016/j.intimp.2022.108878_b0065) 2017; 46 Nakasa (10.1016/j.intimp.2022.108878_b0235) 2008; 58 10.1016/j.intimp.2022.108878_b0135 Lin (10.1016/j.intimp.2022.108878_b0175) 2021; 163 Yoo (10.1016/j.intimp.2022.108878_b0085) 2012; 209 Aletaha (10.1016/j.intimp.2022.108878_b0035) 2018; 320 Walter (10.1016/j.intimp.2022.108878_b0080) 2011; 334 Li (10.1016/j.intimp.2022.108878_b0190) 2019; 23 Li (10.1016/j.intimp.2022.108878_b0125) 2018; 10 Wang (10.1016/j.intimp.2022.108878_b0240) 2017; 42 Yang (10.1016/j.intimp.2022.108878_b0205) 2020; 46 Lee (10.1016/j.intimp.2022.108878_b0045) 2001; 358 |
References_xml | – volume: 23 start-page: 7116 year: 2019 end-page: 7120 ident: b0190 article-title: LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway publication-title: J Cell Mol Med contributor: fullname: Liu – volume: 450 start-page: 844 year: 2014 end-page: 850 ident: b0165 article-title: Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer publication-title: Biochem Biophys Res Commun contributor: fullname: He – volume: 11 start-page: 209 year: 2010 ident: b0225 article-title: MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients publication-title: BMC Musculoskelet Disord contributor: fullname: Ochi – volume: 2 start-page: 111 year: 2012 end-page: 123 ident: b0120 article-title: The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult publication-title: Cell reports contributor: fullname: Zhang – volume: 9 start-page: 1 year: 2007 end-page: 16 ident: b0095 article-title: Cells of the synovium in rheumatoid arthritis publication-title: Macrophages, Arthritis research & therapy contributor: fullname: Burmester – volume: 358 start-page: 903 year: 2001 end-page: 911 ident: b0045 article-title: Rheumatoid arthritis publication-title: Lancet contributor: fullname: Weinblatt – volume: 1863 year: 2020 ident: b0105 article-title: Non-coding RNA regulatory networks publication-title: Biochim Biophys Acta Gene Regul Mech contributor: fullname: Orchard – volume: 165 start-page: 152 year: 2019 end-page: 169 ident: b0170 article-title: The many facets of macrophages in rheumatoid arthritis publication-title: Biochem Pharmacol contributor: fullname: Andreakos – volume: 12 start-page: 472 year: 2016 end-page: 485 ident: b0090 article-title: Macrophage heterogeneity in the context of rheumatoid arthritis publication-title: Nat. Rev. Rheumatol. contributor: fullname: Feldmann – volume: 62 start-page: 2569 year: 2010 end-page: 2581 ident: b0005 article-title: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative publication-title: Arthritis Rheum. contributor: fullname: Cohen – volume: 136 start-page: 629 year: 2009 end-page: 641 ident: b0115 article-title: Evolution and functions of long noncoding RNAs publication-title: Cell contributor: fullname: Reik – volume: 39 start-page: 610 year: 2018 end-page: 623 ident: b0075 article-title: A Therapeutic Target in Rheumatoid Arthritis? publication-title: Trends Pharmacol Sci contributor: fullname: Stress – volume: 71 start-page: 1567 year: 2012 end-page: 1572 ident: b0040 article-title: Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells publication-title: Ann. Rheum. Dis. contributor: fullname: Conti – volume: 17 start-page: 445 year: 2020 end-page: 457 ident: b0215 article-title: Increase in MEG3, MALAT1, NEAT1 significantly predicts the clinical parameters in patients with rheumatoid arthritis publication-title: Per Med contributor: fullname: Ghosh – volume: 42 start-page: 2481 year: 2017 end-page: 2491 ident: b0240 article-title: MicroRNA-199a-5p induced autophagy and inhibits the pathogenesis of ankylosing spondylitis by modulating the mTOR signaling via directly targeting Ras homolog enriched in brain (Rheb) publication-title: Cell. Physiol. Biochem. contributor: fullname: Cui – volume: 4 start-page: 1 year: 2002 end-page: 8 ident: b0020 article-title: Epidemiology and genetics of rheumatoid arthritis publication-title: Arthritis research & therapy contributor: fullname: Pearson – volume: 12 start-page: 2395 year: 2015 end-page: 2401 ident: b0230 article-title: Downregulation of microRNA-221 decreases migration and invasion in fibroblast-like synoviocytes in rheumatoid arthritis publication-title: Mol Med Rep contributor: fullname: Yang – volume: 320 start-page: 1360 year: 2018 end-page: 1372 ident: b0035 article-title: Diagnosis and management of rheumatoid arthritis: a review publication-title: JAMA contributor: fullname: Smolen – volume: 10 start-page: 6757 year: 2018 ident: b0125 article-title: MALAT1: a potential biomarker in cancer publication-title: Cancer management and research contributor: fullname: Zhu – volume: 209 start-page: 871 year: 2012 end-page: 886 ident: b0085 article-title: A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis publication-title: J. Exp. Med. contributor: fullname: Kim – volume: 51 year: 2018 ident: b0145 article-title: Long non-coding RNAs in rheumatoid arthritis publication-title: Cell Prolif contributor: fullname: Wu – volume: 217 start-page: 661 year: 1995 end-page: 667 ident: b0100 article-title: Molecular cloning of a novel macrophage maturation-associated transcript encoding a protein with several potential transmembrane domains publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Andreesen – volume: 13 start-page: 1 year: 2011 end-page: 14 ident: b0030 article-title: Advances in rheumatology: new targeted therapeutics publication-title: Arthritis research & therapy contributor: fullname: Kalden – volume: 4 start-page: 18001 year: 2018 ident: b0010 article-title: Rheumatoid arthritis publication-title: Nat Rev Dis Primers contributor: fullname: Yamamoto – volume: 245 start-page: 69 year: 2022 end-page: 78 ident: b9000 article-title: The MALAT1-H19/miR-19b-3p axis can be a fingerprint for diabetic neuropathy publication-title: Immunology Letters contributor: fullname: Afshar Hezarkhani – volume: 163 start-page: 60 year: 2021 end-page: 73 ident: b0175 article-title: PAQR11 modulates monocyte-to-macrophage differentiation and pathogenesis of rheumatoid arthritis publication-title: Immunology contributor: fullname: Chen – volume: 27 start-page: 862 year: 2017 end-page: 867 ident: b0160 article-title: Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23 publication-title: Mod. Rheumatol. contributor: fullname: Nicknam – volume: 58 start-page: 1284 year: 2008 end-page: 1292 ident: b0235 article-title: Expression of microRNA-146 in rheumatoid arthritis synovial tissue publication-title: Arthritis Rheum. contributor: fullname: Asahara – volume: 46 start-page: 183 year: 2017 end-page: 196 ident: b0065 article-title: Immunopathogenesis of rheumatoid arthritis publication-title: Immunity contributor: fullname: McInnes – volume: 46 start-page: 813 year: 2020 end-page: 820 ident: b0205 article-title: LncRNA H19 aggravates TNF-α-induced inflammatory injury via TAK1 pathway in MH7A cells publication-title: BioFactors contributor: fullname: Jia – volume: 9 start-page: 1662 year: 2018 ident: b0060 article-title: Apremilast ameliorates experimental arthritis via suppression of Th1 and Th17 cells and enhancement of CD4+ Foxp3+ regulatory T cells differentiation publication-title: Front. Immunol. contributor: fullname: Lin – volume: 18 start-page: 589 year: 2012 end-page: 598 ident: b0070 article-title: ER stress-induced inflammation: does it aid or impede disease progression? publication-title: Trends Mol. Med. contributor: fullname: Agostinis – volume: 10 start-page: 3129 year: 2019 ident: b0185 article-title: Non-coding RNAs in Rheumatoid Arthritis: from Bench to Bedside publication-title: Front Immunol contributor: fullname: Wang – volume: 24 start-page: 6881 year: 2020 end-page: 6892 ident: b0245 article-title: MiR-1-3p facilitates Th17 differentiation associating with multiple sclerosis via targeting ETS1 publication-title: Eur Rev Med Pharmacol Sci contributor: fullname: Zhang – start-page: 182 year: 2006 end-page: 188 ident: b0015 article-title: Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review publication-title: Seminars in arthritis and rheumatism, Elsevier contributor: fullname: Drosos – volume: 376 start-page: 1094 year: 2010 end-page: 1108 ident: b0050 article-title: Rheumatoid arthritis publication-title: Lancet contributor: fullname: Huizinga – volume: 8 year: 2013 ident: b0140 article-title: Systematic transcriptome wide analysis of lncRNA-miRNA interactions publication-title: PLoS ONE contributor: fullname: Scaria – volume: 91 start-page: 46 year: 2000 end-page: 50 ident: b0130 article-title: Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection publication-title: Am. J. Med. Genet. contributor: fullname: Hochberg – year: 2012 ident: b0180 article-title: Long Noncoding RNAs are Rarely Translated in Two Human Cell Lines publication-title: Genome Res. contributor: fullname: Giddings – volume: 42 start-page: 415 year: 1999 end-page: 420 ident: b0025 article-title: The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985 publication-title: Arthritis & Rheumatism: Official Journal of the American College of Rheumatology contributor: fullname: O'Fallon – volume: 35 start-page: 1263 year: 1996 end-page: 1268 ident: b0055 article-title: Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ publication-title: Rheumatology contributor: fullname: Bresnihan – volume: 52 start-page: 1138 year: 2005 end-page: 1147 ident: b0150 article-title: Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort publication-title: Arthritis Rheum. contributor: fullname: Eritematoso – volume: 13 start-page: 1211 year: 1999 end-page: 1233 ident: b0155 article-title: Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls publication-title: Genes Dev. contributor: fullname: Kaufman – volume: 234 start-page: 22477 year: 2019 end-page: 22484 ident: b0200 article-title: Knockdown of lncRNA NEAT1 inhibits Th17/CD4+ T cell differentiation through reducing the STAT3 protein level publication-title: J. Cell. Physiol. contributor: fullname: Wu – volume: 334 start-page: 1081 year: 2011 end-page: 1086 ident: b0080 article-title: The unfolded protein response: from stress pathway to homeostatic regulation publication-title: Science contributor: fullname: Ron – volume: 15 start-page: 7 year: 2014 end-page: 21 ident: b0110 article-title: Long non-coding RNAs: new players in cell differentiation and development publication-title: Nat. Rev. Genet. contributor: fullname: Bozzoni – volume: 93 year: 2021 ident: b0210 article-title: LncRNA H19 regulates macrophage polarization and promotes Freund’s complete adjuvant-induced arthritis by upregulating KDM6A publication-title: Int. Immunopharmacol. contributor: fullname: Zhang – volume: 50 start-page: 408 year: 2019 end-page: 420 ident: b0195 article-title: LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis publication-title: EBioMedicine contributor: fullname: Zheng – volume: 17 start-page: 445 issue: 6 year: 2020 ident: 10.1016/j.intimp.2022.108878_b0215 article-title: Increase in MEG3, MALAT1, NEAT1 significantly predicts the clinical parameters in patients with rheumatoid arthritis publication-title: Per Med doi: 10.2217/pme-2020-0009 contributor: fullname: Chatterjee – volume: 13 start-page: 1 issue: 1 year: 2011 ident: 10.1016/j.intimp.2022.108878_b0030 article-title: Advances in rheumatology: new targeted therapeutics publication-title: Arthritis research & therapy contributor: fullname: Tak – volume: 245 start-page: 69 year: 2022 ident: 10.1016/j.intimp.2022.108878_b9000 article-title: The MALAT1-H19/miR-19b-3p axis can be a fingerprint for diabetic neuropathy publication-title: Immunology Letters doi: 10.1016/j.imlet.2022.03.004 contributor: fullname: Rajabinejad – volume: 71 start-page: 1567 issue: 9 year: 2012 ident: 10.1016/j.intimp.2022.108878_b0040 article-title: Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells publication-title: Ann. Rheum. Dis. doi: 10.1136/annrheumdis-2011-201052 contributor: fullname: Kong – volume: 10 start-page: 6757 year: 2018 ident: 10.1016/j.intimp.2022.108878_b0125 article-title: MALAT1: a potential biomarker in cancer publication-title: Cancer management and research doi: 10.2147/CMAR.S169406 contributor: fullname: Li – volume: 9 start-page: 1 issue: 6 year: 2007 ident: 10.1016/j.intimp.2022.108878_b0095 article-title: Cells of the synovium in rheumatoid arthritis publication-title: Macrophages, Arthritis research & therapy contributor: fullname: Kinne – volume: 320 start-page: 1360 issue: 13 year: 2018 ident: 10.1016/j.intimp.2022.108878_b0035 article-title: Diagnosis and management of rheumatoid arthritis: a review publication-title: JAMA doi: 10.1001/jama.2018.13103 contributor: fullname: Aletaha – volume: 376 start-page: 1094 issue: 9746 year: 2010 ident: 10.1016/j.intimp.2022.108878_b0050 article-title: Rheumatoid arthritis publication-title: Lancet doi: 10.1016/S0140-6736(10)60826-4 contributor: fullname: Scott – volume: 136 start-page: 629 issue: 4 year: 2009 ident: 10.1016/j.intimp.2022.108878_b0115 article-title: Evolution and functions of long noncoding RNAs publication-title: Cell doi: 10.1016/j.cell.2009.02.006 contributor: fullname: Ponting – volume: 62 start-page: 2569 issue: 9 year: 2010 ident: 10.1016/j.intimp.2022.108878_b0005 article-title: 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative publication-title: Arthritis Rheum. doi: 10.1002/art.27584 contributor: fullname: Aletaha – year: 2012 ident: 10.1016/j.intimp.2022.108878_b0180 article-title: Long Noncoding RNAs are Rarely Translated in Two Human Cell Lines publication-title: Genome Res. contributor: fullname: Khatun – volume: 163 start-page: 60 issue: 1 year: 2021 ident: 10.1016/j.intimp.2022.108878_b0175 article-title: PAQR11 modulates monocyte-to-macrophage differentiation and pathogenesis of rheumatoid arthritis publication-title: Immunology doi: 10.1111/imm.13303 contributor: fullname: Lin – volume: 93 year: 2021 ident: 10.1016/j.intimp.2022.108878_b0210 article-title: LncRNA H19 regulates macrophage polarization and promotes Freund’s complete adjuvant-induced arthritis by upregulating KDM6A publication-title: Int. Immunopharmacol. doi: 10.1016/j.intimp.2021.107402 contributor: fullname: Zhu – volume: 51 issue: 1 year: 2018 ident: 10.1016/j.intimp.2022.108878_b0145 article-title: Long non-coding RNAs in rheumatoid arthritis publication-title: Cell Prolif doi: 10.1111/cpr.12404 contributor: fullname: Li – start-page: 182 year: 2006 ident: 10.1016/j.intimp.2022.108878_b0015 article-title: Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review publication-title: Seminars in arthritis and rheumatism, Elsevier doi: 10.1016/j.semarthrit.2006.08.006 contributor: fullname: Alamanos – volume: 1863 issue: 6 year: 2020 ident: 10.1016/j.intimp.2022.108878_b0105 article-title: Non-coding RNA regulatory networks publication-title: Biochim Biophys Acta Gene Regul Mech doi: 10.1016/j.bbagrm.2019.194417 contributor: fullname: Panni – volume: 18 start-page: 589 issue: 10 year: 2012 ident: 10.1016/j.intimp.2022.108878_b0070 article-title: ER stress-induced inflammation: does it aid or impede disease progression? publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2012.06.010 contributor: fullname: Garg – volume: 23 start-page: 7116 issue: 10 year: 2019 ident: 10.1016/j.intimp.2022.108878_b0190 article-title: LncRNA MEG3 inhibits rheumatoid arthritis through miR-141 and inactivation of AKT/mTOR signalling pathway publication-title: J Cell Mol Med doi: 10.1111/jcmm.14591 contributor: fullname: Li – volume: 58 start-page: 1284 issue: 5 year: 2008 ident: 10.1016/j.intimp.2022.108878_b0235 article-title: Expression of microRNA-146 in rheumatoid arthritis synovial tissue publication-title: Arthritis Rheum. doi: 10.1002/art.23429 contributor: fullname: Nakasa – volume: 450 start-page: 844 issue: 1 year: 2014 ident: 10.1016/j.intimp.2022.108878_b0165 article-title: Monocyte to macrophage differentiation-associated (MMD) targeted by miR-140-5p regulates tumor growth in non-small cell lung cancer publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2014.06.075 contributor: fullname: Li – volume: 334 start-page: 1081 issue: 6059 year: 2011 ident: 10.1016/j.intimp.2022.108878_b0080 article-title: The unfolded protein response: from stress pathway to homeostatic regulation publication-title: Science doi: 10.1126/science.1209038 contributor: fullname: Walter – volume: 15 start-page: 7 issue: 1 year: 2014 ident: 10.1016/j.intimp.2022.108878_b0110 article-title: Long non-coding RNAs: new players in cell differentiation and development publication-title: Nat. Rev. Genet. doi: 10.1038/nrg3606 contributor: fullname: Fatica – volume: 9 start-page: 1662 year: 2018 ident: 10.1016/j.intimp.2022.108878_b0060 article-title: Apremilast ameliorates experimental arthritis via suppression of Th1 and Th17 cells and enhancement of CD4+ Foxp3+ regulatory T cells differentiation publication-title: Front. Immunol. doi: 10.3389/fimmu.2018.01662 contributor: fullname: Chen – volume: 209 start-page: 871 issue: 4 year: 2012 ident: 10.1016/j.intimp.2022.108878_b0085 article-title: A novel pathogenic role of the ER chaperone GRP78/BiP in rheumatoid arthritis publication-title: J. Exp. Med. doi: 10.1084/jem.20111783 contributor: fullname: Yoo – volume: 52 start-page: 1138 issue: 4 year: 2005 ident: 10.1016/j.intimp.2022.108878_b0150 article-title: Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort publication-title: Arthritis Rheum. doi: 10.1002/art.20999 contributor: fullname: Alarcón-Segovia – volume: 42 start-page: 2481 issue: 6 year: 2017 ident: 10.1016/j.intimp.2022.108878_b0240 article-title: MicroRNA-199a-5p induced autophagy and inhibits the pathogenesis of ankylosing spondylitis by modulating the mTOR signaling via directly targeting Ras homolog enriched in brain (Rheb) publication-title: Cell. Physiol. Biochem. doi: 10.1159/000480211 contributor: fullname: Wang – volume: 50 start-page: 408 year: 2019 ident: 10.1016/j.intimp.2022.108878_b0195 article-title: LncRNA PICSAR promotes cell proliferation, migration and invasion of fibroblast-like synoviocytes by sponging miRNA-4701-5p in rheumatoid arthritis publication-title: EBioMedicine doi: 10.1016/j.ebiom.2019.11.024 contributor: fullname: Bi – volume: 234 start-page: 22477 issue: 12 year: 2019 ident: 10.1016/j.intimp.2022.108878_b0200 article-title: Knockdown of lncRNA NEAT1 inhibits Th17/CD4+ T cell differentiation through reducing the STAT3 protein level publication-title: J. Cell. Physiol. doi: 10.1002/jcp.28811 contributor: fullname: Shui – volume: 11 start-page: 209 year: 2010 ident: 10.1016/j.intimp.2022.108878_b0225 article-title: MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients publication-title: BMC Musculoskelet Disord doi: 10.1186/1471-2474-11-209 contributor: fullname: Niimoto – volume: 39 start-page: 610 issue: 7 year: 2018 ident: 10.1016/j.intimp.2022.108878_b0075 article-title: A Therapeutic Target in Rheumatoid Arthritis? publication-title: Trends Pharmacol Sci doi: 10.1016/j.tips.2018.03.010 contributor: fullname: Rahmati – volume: 4 start-page: 18001 year: 2018 ident: 10.1016/j.intimp.2022.108878_b0010 article-title: Rheumatoid arthritis publication-title: Nat Rev Dis Primers doi: 10.1038/nrdp.2018.1 contributor: fullname: Smolen – volume: 35 start-page: 1263 issue: 12 year: 1996 ident: 10.1016/j.intimp.2022.108878_b0055 article-title: Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ publication-title: Rheumatology doi: 10.1093/rheumatology/35.12.1263 contributor: fullname: Mulherin – volume: 4 start-page: 1 issue: 3 year: 2002 ident: 10.1016/j.intimp.2022.108878_b0020 article-title: Epidemiology and genetics of rheumatoid arthritis publication-title: Arthritis research & therapy contributor: fullname: Silman – volume: 10 start-page: 3129 year: 2019 ident: 10.1016/j.intimp.2022.108878_b0185 article-title: Non-coding RNAs in Rheumatoid Arthritis: from Bench to Bedside publication-title: Front Immunol doi: 10.3389/fimmu.2019.03129 contributor: fullname: Wang – volume: 27 start-page: 862 issue: 5 year: 2017 ident: 10.1016/j.intimp.2022.108878_b0160 article-title: Ankylosing spondylitis M-CSF-derived macrophages are undergoing unfolded protein response (UPR) and express higher levels of interleukin-23 publication-title: Mod. Rheumatol. doi: 10.1080/14397595.2016.1259716 contributor: fullname: Rezaiemanesh – volume: 24 start-page: 6881 issue: 12 year: 2020 ident: 10.1016/j.intimp.2022.108878_b0245 article-title: MiR-1-3p facilitates Th17 differentiation associating with multiple sclerosis via targeting ETS1 publication-title: Eur Rev Med Pharmacol Sci contributor: fullname: Li – volume: 46 start-page: 183 issue: 2 year: 2017 ident: 10.1016/j.intimp.2022.108878_b0065 article-title: Immunopathogenesis of rheumatoid arthritis publication-title: Immunity doi: 10.1016/j.immuni.2017.02.006 contributor: fullname: Firestein – volume: 46 start-page: 813 issue: 5 year: 2020 ident: 10.1016/j.intimp.2022.108878_b0205 article-title: LncRNA H19 aggravates TNF-α-induced inflammatory injury via TAK1 pathway in MH7A cells publication-title: BioFactors doi: 10.1002/biof.1659 contributor: fullname: Yang – volume: 8 issue: 2 year: 2013 ident: 10.1016/j.intimp.2022.108878_b0140 article-title: Systematic transcriptome wide analysis of lncRNA-miRNA interactions publication-title: PLoS ONE doi: 10.1371/journal.pone.0053823 contributor: fullname: Jalali – ident: 10.1016/j.intimp.2022.108878_b0135 doi: 10.1002/mc.10075 – volume: 165 start-page: 152 year: 2019 ident: 10.1016/j.intimp.2022.108878_b0170 article-title: The many facets of macrophages in rheumatoid arthritis publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2019.03.029 contributor: fullname: Siouti – volume: 358 start-page: 903 issue: 9285 year: 2001 ident: 10.1016/j.intimp.2022.108878_b0045 article-title: Rheumatoid arthritis publication-title: Lancet doi: 10.1016/S0140-6736(01)06075-5 contributor: fullname: Lee – volume: 12 start-page: 472 issue: 8 year: 2016 ident: 10.1016/j.intimp.2022.108878_b0090 article-title: Macrophage heterogeneity in the context of rheumatoid arthritis publication-title: Nat. Rev. Rheumatol. doi: 10.1038/nrrheum.2016.91 contributor: fullname: Udalova – volume: 2 start-page: 111 issue: 1 year: 2012 ident: 10.1016/j.intimp.2022.108878_b0120 article-title: The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult publication-title: Cell reports doi: 10.1016/j.celrep.2012.06.003 contributor: fullname: Zhang – ident: 10.1016/j.intimp.2022.108878_b0220 doi: 10.1093/nar/gkn714 – volume: 12 start-page: 2395 issue: 2 year: 2015 ident: 10.1016/j.intimp.2022.108878_b0230 article-title: Downregulation of microRNA-221 decreases migration and invasion in fibroblast-like synoviocytes in rheumatoid arthritis publication-title: Mol Med Rep doi: 10.3892/mmr.2015.3642 contributor: fullname: Yang – volume: 91 start-page: 46 issue: 1 year: 2000 ident: 10.1016/j.intimp.2022.108878_b0130 article-title: Imprinted H19 gene expression in embryogenesis and human cancer: the oncofetal connection publication-title: Am. J. Med. Genet. doi: 10.1002/(SICI)1096-8628(20000306)91:1<46::AID-AJMG8>3.0.CO;2-I contributor: fullname: Ariel – volume: 13 start-page: 1211 issue: 10 year: 1999 ident: 10.1016/j.intimp.2022.108878_b0155 article-title: Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls publication-title: Genes Dev. doi: 10.1101/gad.13.10.1211 contributor: fullname: Kaufman – volume: 217 start-page: 661 issue: 2 year: 1995 ident: 10.1016/j.intimp.2022.108878_b0100 article-title: Molecular cloning of a novel macrophage maturation-associated transcript encoding a protein with several potential transmembrane domains publication-title: Biochem. Biophys. Res. Commun. doi: 10.1006/bbrc.1995.2825 contributor: fullname: Rehli – volume: 42 start-page: 415 issue: 3 year: 1999 ident: 10.1016/j.intimp.2022.108878_b0025 article-title: The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985 publication-title: Arthritis & Rheumatism: Official Journal of the American College of Rheumatology doi: 10.1002/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z contributor: fullname: Gabriel |
SSID | ssj0017041 |
Score | 2.4552305 |
Snippet | •MALAT1 and H19 may be candidates as potential biomarkers in rheumatoid arthritis.•MALAT1 and H19 positively correlated with MMD and RA severity.•DMARDs plus... Rheumatoid arthritis (RA) is a systemic autoimmune disease with chronic inflammation characterized by joint damage and even extra-articular involvement. In... BACKGROUNDRheumatoid arthritis (RA) is a systemic autoimmune disease with chronic inflammation characterized by joint damage and even extra-articular... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 108878 |
SubjectTerms | DMARDs HSPA5 MMD ncRNAs Rheumatoid arthritis |
Title | Efficacy of DMARDs and methylprednisolone treatment on the gene expression levels of HSPA5, MMD, and non-coding RNAs MALAT1, H19, miR-199a-5p, and miR-1-3p, in patients with rheumatoid arthritis |
URI | https://dx.doi.org/10.1016/j.intimp.2022.108878 https://www.ncbi.nlm.nih.gov/pubmed/35623291 https://search.proquest.com/docview/2671270904 |
Volume | 108 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZtymAvY-suzS7lDEafrCWW7ch-NE2Ld3EIaQp9M5YlU49WDnECy8t-3H7Zjiw7ZbAx2JstLFn4HOl8x_r0iZAPgcc5D3OfSswtqB-JggpP-nQsWDgupI8Q1WwUTmeT5Nr_fBPcHJDzfi-MoVV2c7-d09vZuisZdV9ztKqq0RVmHhzRcsRYK6oSHZIjDEe-PyBH8acvyWy_mMDHvpVNxTnBVOh30LU0r0pvqnsjXMmY4duF5ry1P0eovyHQNhJdPiVPOggJse3lM3Kg9DF5ZA-V3B2Ts7lVo945sHzYXNU4cAbzB53q3XPy88LIR-CDUJcwTePFtIFcSzCHSu_uVmsldYWeWWsFezo61BoQMgK6nQL1vWPRargz3KPGNJRczePAgTSdOm1ruta0qE2EhMUsbiCNv8ZL14HEjRy4rxaGg5LTYGWfbguoh3eVhk7ztQHzsxjWt2qL8LquJKCBblsxphfk-vJieZ7Q7kgHWrCIbWgQqDJUCLM4K_IwwGRNTQzGK1kkI-EVQnCERFyJSOVl6QqJWXMpwomSPCzQd7yXZID9VicEXIHZqlJl7kdjX3KeK4_LPA9KvEQMrIaE9mbMVla5I-spbd8ya_bMmD2zZh8S3ts6-80DMwwu_6j5vneNDAenWXHJtaq3TcYm3KzsYweH5JX1mX1fPIM8WeS-_u_3viGPzZ0lD78lg816q94hRNqIU3L48Yd72g2EX57cDxo |
link.rule.ids | 315,786,790,4521,24144,27955,27956,45618,45712 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFLXGEIIXBANG-bxIaE8xbZykTh6jdVOApqq6TtpbFMeOFrQ5VdNK9IUfxy_jOk46IYGQeEscJ7nKvbbPjY-PCfkYeJzzMPepxNyC-pEoqPCkT0eChaNC-ghRzULhdDZOLv0vV8HVATnt18IYWmXX99s-ve2tu5Jh9zWHq6oaXmDmwREtR4y1oirRPXLfoAHD6_r0Y8_zcPnIt6Kp2COY6v36uZbkVelNdWtkKxkzbLvQ7Lb25_Hpb_izHYfOn5DHHYCE2Nr4lBwofUQe2C0ld0fkZG61qHcOLO-WVjUOnMD8TqV694z8PDPiEVgR6hImabyYNJBrCWZL6d3Naq2krjAua61gT0aHWgMCRsCgU6C-dxxaDTeGedSYByUX8zhwIE0nTvs0XWta1GZ8hMUsbiCNp_HSdSBxIwduq4VhoOQ0WNnabQH18KzS0Cm-NmB-FcP6Wm0RXNeVBHTPdSvF9Jxcnp8tTxPabehACxaxDQ0CVYYKQRZnRR4GmKqpsUF4JYtkJLxCCI6AiCsRqbwsXSExZy5FOFaShwVGjveCHKLd6iUBV2CuqlSZ-9HIl5znyuMyz4MSDxEBqwGhvRuzldXtyHpC27fMuj0zbs-s2weE977Ofou_DIeWf9z5oQ-NDJummW_Jtaq3TcbG3Mzro4EDcmxjZm-LZ3Ani9xX__3e9-Rhskyn2fTz7Otr8shcsTTiN-Rws96qtwiWNuJd2xh-AQraD-8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+of+DMARDs+and+methylprednisolone+treatment+on+the+gene+expression+levels+of+HSPA5%2C+MMD%2C+and+non-coding+RNAs+MALAT1%2C+H19%2C+miR-199a-5p%2C+and+miR-1-3p%2C+in+patients+with+rheumatoid+arthritis&rft.jtitle=International+immunopharmacology&rft.au=Mahmoudi%2C+Zahra&rft.au=Karamali%2C+Negin&rft.au=Roghani%2C+Seyed+Askar&rft.au=Assar%2C+Shirin&rft.date=2022-07-01&rft.pub=Elsevier+B.V&rft.issn=1567-5769&rft.eissn=1878-1705&rft.volume=108&rft_id=info:doi/10.1016%2Fj.intimp.2022.108878&rft.externalDocID=S1567576922003629 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1567-5769&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1567-5769&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1567-5769&client=summon |